Conversion of human fibroblasts into multipotent cells by cell-penetrating peptides

被引:3
|
作者
Kikuchi, Jiro [1 ]
Hayashi, Nakanobu [2 ]
Osada, Naoki [1 ]
Sugitani, Masahiko [3 ,4 ]
Furukawa, Yusuke [1 ]
机构
[1] Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[2] Gene Try Co, Itabashi Ku, Tokyo 1738610, Japan
[3] Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738610, Japan
[4] Ageo Cent Gen Hosp, Pathol Div, Ageo, Saitama 3628588, Japan
关键词
Cell-penetrating peptide; Multipotent cell; Histone deacetylase; Lysine specific demethylase 1; Regenerative medicine; PLURIPOTENT STEM-CELLS; DELIVERY; GENE; INDUCTION; VECTOR; LSD1;
D O I
10.1016/j.bbrc.2019.08.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential application of human induced pluripotent stem cells (hiPSCs) brings great expectations to regenerative medicine. However, several safety concerns, such as oncogenic transformation, remain. A number of methods have been developed to produce hiPSCs with potentially reduced risks. Cell-penetrating peptides (CPPs) are expected to improve the efficiency of nonviral reprogramming by delivering biologically active molecules into cells. Here, we show that the transfection of CPPs alone into normal adult human fibroblasts generated embryonic body (EB)-like cell clusters in the absence of reprogramming factors. The CPP-generated cell clusters were positive for a set of multipotency markers and differentiated into endodermal, ectodermal, and mesodermal cells in vitro. These results suggest that CPPs converted normal human adult somatic cells into multipotent cells. Moreover, we show that CPPs dissociated histone deacetylase 1 and lysine-specific demethylase 1 from the promoter/enhancer regions of reprogramming factors to reactivate their expression. This is the first report of an easy and quick method for somatic cell reprogramming by CPPs and a novel mechanism of reprogramming. The potential application of CPP-generated multipotent cells resolves several concerns, especially safety issues, in regenerative medicine. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [1] Cell-penetrating peptides
    Lindgren, M
    Hallbrink, M
    Prochiantz, A
    Langel, U
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) : 99 - 103
  • [2] Cell-penetrating peptides transport therapeutics into cells
    Ramsey, Joshua D.
    Flynn, Nicholas H.
    PHARMACOLOGY & THERAPEUTICS, 2015, 154 : 78 - 86
  • [3] INTERNALIZATION OF CELL-PENETRATING PEPTIDES IN PLANT CELLS
    Myrberg, H.
    Maee, M.
    Jiang, Y.
    Valkna, A.
    Langel, U.
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 192 - 192
  • [4] Identification and Characterization of a New Family of Cell-penetrating Peptides CYCLIC CELL-PENETRATING PEPTIDES
    Cascales, Laura
    Henriques, Sonia T.
    Kerr, Markus C.
    Huang, Yen-Hua
    Sweet, Matthew J.
    Daly, Norelle L.
    Craik, David J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (42) : 36932 - 36943
  • [5] The case for cell-penetrating peptides
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 615 - 616
  • [6] The Pharmacokinetics of Cell-Penetrating Peptides
    Sarko, Dikran
    Beijer, Barbro
    Boy, Regine Garcia
    Nothelfer, Eva-Maria
    Leotta, Karin
    Eisenhut, Michael
    Altmann, Annette
    Haberkorn, Uwe
    Mier, Walter
    MOLECULAR PHARMACEUTICS, 2010, 7 (06) : 2224 - 2231
  • [7] DESIGN OF CELL-PENETRATING PEPTIDES
    Bode, Saskia
    Thevenin, Marion
    Sagan, Sandrine
    Aussedat, Baptiste
    Aubry, Soline
    Jiao, Chen-Yu
    Lavielle, Solange
    Chassaing, Gerard
    Burlina, Fabienne
    BIOLOGICALLY ACTIVE PEPTIDES, 2011, 13 : 4 - 7
  • [8] Cell-Penetrating Peptides and Transportan
    Langel, Ulo
    PHARMACEUTICS, 2021, 13 (07)
  • [9] Prediction of Cell-Penetrating Peptides
    Mattias Hällbrink
    Kalle Kilk
    Anna Elmquist
    Pontus Lundberg
    Maria Lindgren
    Yang Jiang
    Margus Pooga
    Ursel Soomets
    Ülo Langel
    International Journal of Peptide Research and Therapeutics, 2005, 11 : 249 - 259
  • [10] Predicting cell-penetrating peptides
    Hansen, Mats
    Kilk, Kalle
    Langel, Ulo
    ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (4-5) : 572 - 579